Smoking and suicide: a brief overview
- PMID: 18676099
- PMCID: PMC2585177
- DOI: 10.1016/j.drugalcdep.2008.06.003
Smoking and suicide: a brief overview
Abstract
This article provides a brief overview of the rationales, possible mechanisms and epidemiological data on the association of smoking, smoking cessation and cessation medications with suicide. Current smoking is reliably associated with suicide both in case-control and cohort studies. The three most plausible (but relatively untested) explanations for the association are that smokers have pre-existing conditions that increase their risk for suicide, smoking causes painful and debilitating conditions that might lead to suicide, and smoking decreases serotonin and monoamine oxidase levels. Stopping smoking appears to lead to major depression in some smokers; thus, it could induce suicide; however, smoking cessation has not been associated with suicide in the few studies available. Regulatory agencies have stated bupropion, rimonabant and varenicline appear to be associated with suicide; however, the data for these statements have not been presented in sufficient detail to assess their validity. Most prior data have come from post hoc analyses. Studies that a priori focus on understanding smoking and suicide are now needed.
References
-
- Anthenelli RM, Maxwell RA. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls. Alcoholism: Clinical & Experimental Research. 2000;24:987–995. - PubMed
-
- Anthonisen N, Connett J, Kiley J, Altose M, Bailey W, Buist A, Conway W, Jr, Enright P, Kanner R, O'Hara P, Owens G, Scanlon P, Tashkin D, Wise R. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV. JAMA. 1994;272:1497–1505. - PubMed
-
- Ayers S, Tobias JD. Bupropion overdose in an adolescent. Pediatr Emerg Care. 2001;17:104–106. - PubMed
-
- Benwell MEM, Balfour DJK, Anderson JM. Smoking-associated changes in the serotonergic systems of discrete regions of human brain. Psychopharm. 1990;102:68–72. - PubMed
-
- Berggren U, Fahike C, Eriksson M, Balldin J. Tobacco use is associated with reduced central serotonergic neurotransmission in Type 1 alcohol-dependent individuals. Alcohol Clin Exp Res. 2003;27:1257–1261. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical